163 related articles for article (PubMed ID: 10427487)
1. Competitive polymerase chain reaction for the determination of N-myc amplification in neuroblastoma: report of clinical cases.
Hasan Z; Inoue A; Ikeda H; Kamii Y; Obana K; Yokomori K; Tsuchida Y; Hemmi H; Shimatake H
Eur J Pediatr Surg; 1999 Jun; 9(3):138-41. PubMed ID: 10427487
[TBL] [Abstract][Full Text] [Related]
2. Expressions of N-myc and ras oncogene products in neuroblastoma and their correlations with prognosis.
Nakada K; Fujioka T; Kitagawa H; Takakuwa T; Yamate N
Jpn J Clin Oncol; 1993 Jun; 23(3):149-55. PubMed ID: 8350488
[TBL] [Abstract][Full Text] [Related]
3. Detection of n-myc gene amplification in neuroblastoma by comparative, in situ,and real-time polymerase chain reaction.
Melegh Z; Bálint I; Tóth E; Csernák E; Szentirmay Z; Nagy K
Pediatr Pathol Mol Med; 2003; 22(3):213-22. PubMed ID: 12746172
[TBL] [Abstract][Full Text] [Related]
4. [N-myc status of neuroblastoma from bone marrow cells].
Brack T; Finckenstein FG; Kabisch H
Klin Padiatr; 1991; 203(4):323-7. PubMed ID: 1942939
[TBL] [Abstract][Full Text] [Related]
5. Detection of N-myc amplification in neuroblastomas using Southern blotting on fine needle aspirates.
Barroca H; Carvalho JL; da Costa MJ; Cirnes L; Seruca R; Schmitt FC
Acta Cytol; 2001; 45(2):169-72. PubMed ID: 11284301
[TBL] [Abstract][Full Text] [Related]
6. Determination of N-myc gene amplification in neuroblastoma by differential polymerase chain reaction.
Gilbert J; Norris MD; Haber M; Kavallaris M; Marshall GM; Stewart BW
Mol Cell Probes; 1993 Jun; 7(3):227-34. PubMed ID: 8366868
[TBL] [Abstract][Full Text] [Related]
7. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification.
Castle VP; Heidelberger KP; Bromberg J; Ou X; Dole M; Nuñez G
Am J Pathol; 1993 Dec; 143(6):1543-50. PubMed ID: 8256847
[TBL] [Abstract][Full Text] [Related]
8. [Detection of n-myc gene amplification in neuroblastoma using polymerase chain reaction based methods].
Melegh Z; Bálint I; Nagy K; Magyarosy E; Galántai I; Szentirmay Z
Magy Onkol; 2002; 46(1):43-8. PubMed ID: 12050681
[TBL] [Abstract][Full Text] [Related]
9. The use of fine-needle aspiration cytology in the molecular characterization of neuroblastoma in children.
Fröstad B; Martinsson T; Tani E; Falkmer U; Darnfors C; Skoog L; Kogner P
Cancer; 1999 Apr; 87(2):60-8. PubMed ID: 10227595
[TBL] [Abstract][Full Text] [Related]
10. Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification.
Cohn SL; Salwen H; Quasney MW; Ikegaki N; Cowan JM; Herst CV; Kennett RH; Rosen ST; DiGiuseppe JA; Brodeur GM
Oncogene; 1990 Dec; 5(12):1821-7. PubMed ID: 2284101
[TBL] [Abstract][Full Text] [Related]
11. Rapid and accurate determination of MYCN copy number and 1p deletion in neuroblastoma by quantitative PCR.
Anderson J; Gibson S; Williamson D; Rampling D; Austin C; Shipley J; Sebire N; Brock P
Pediatr Blood Cancer; 2006 Jun; 46(7):820-4. PubMed ID: 16220551
[TBL] [Abstract][Full Text] [Related]
12. Inverse expression of MYCN and mdr-1 in human neuroblastoma.
Nakagawara A; Kadomatsu K; Sato S; Kohno K; Takano H; Kuwano M
Prog Clin Biol Res; 1991; 366():11-9. PubMed ID: 2068131
[No Abstract] [Full Text] [Related]
13. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
[TBL] [Abstract][Full Text] [Related]
14. Retrospective study on amplification of N-myc and c-myc genes in pediatric solid tumors and its association with prognosis and tumor differentiation.
Tsuda H; Shimosato Y; Upton MP; Yokota J; Terada M; Ohira M; Sugimura T; Hirohashi S
Lab Invest; 1988 Sep; 59(3):321-7. PubMed ID: 3411933
[TBL] [Abstract][Full Text] [Related]
15. The characteristics of mediastinal neuroblastoma.
Suita S; Tajiri T; Sera Y; Takamatsu H; Mizote H; Ohgami H; Kurosaki N; Hara T; Okamura J; Miyazaki S; Sugimoto T; Kawakami K; Tsuneyoshi M; Tasaka H; Yano H; Akiyama H; Ikeda K
Eur J Pediatr Surg; 2000 Dec; 10(6):353-9. PubMed ID: 11215774
[TBL] [Abstract][Full Text] [Related]
16. Composite pheochromocytoma: a clinicopathologic and molecular comparison with ordinary pheochromocytoma and neuroblastoma.
Comstock JM; Willmore-Payne C; Holden JA; Coffin CM
Am J Clin Pathol; 2009 Jul; 132(1):69-73. PubMed ID: 19864235
[TBL] [Abstract][Full Text] [Related]
17. [N-myc gene copies in children with neuroblastoma and its clinical significance].
Ma XL; Gong LP; Zhou CJ; Zhang DW; Jin M; Wang HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1447-51. PubMed ID: 23257451
[TBL] [Abstract][Full Text] [Related]
18. N-myc amplification and cell proliferation rate in human neuroblastoma.
Pession A; Trerè D; Perri P; Rondelli R; Montanaro L; Mantovani W; Derenzini M; Paolucci G
J Pathol; 1997 Nov; 183(3):339-44. PubMed ID: 9422991
[TBL] [Abstract][Full Text] [Related]
19. Antiblastic treatment does not affect N-myc gene amplification in neuroblastoma.
Tonini GP; Verdona G; Garaventa A; Cornaglia-Ferraris P
Anticancer Res; 1987; 7(4B):729-32. PubMed ID: 3314672
[TBL] [Abstract][Full Text] [Related]
20. Consistent N-myc copy number in simultaneous or consecutive neuroblastoma samples from sixty individual patients.
Brodeur GM; Hayes FA; Green AA; Casper JT; Wasson J; Wallach S; Seeger RC
Cancer Res; 1987 Aug; 47(16):4248-53. PubMed ID: 2440561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]